AI Insight
Glaucoma is the leading cause of irreversible vision loss globally, but often progresses asymptomatically for years before diagnosis, resulting in permanent optic nerve damage. Genetic information shows promise in predicting disease onset and progression, potentially enabling earlier detection. Targeted screening using genetic data could identify at-risk individuals before irreversible damage occurs.
Why it matters
Early detection of glaucoma through genetic screening could prevent permanent vision loss in millions of people worldwide by enabling intervention before optic nerve damage becomes irreversible. This approach could transform glaucoma management from reactive treatment to proactive prevention.
Understand the Science
Glaucoma is the leading cause of irreversible visual impairment worldwide. Because the disease often progresses without symptoms for years, many patients are diagnosed only after permanent damage to the optic nerve has already occurred. Earlier detection through targeted screening could help prevent vision loss.
Source: Genetic information helps predict the onset and progression of glaucoma